gimli
ERIS stock analysis context
ERIS LIFESCIENCES Stock Context for AI Screening
ERIS LIFESCIENCES LIMITED is a mid-cap stock in Healthcare. This page summarizes key screening signals for ERIS LIFESCIENCES, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about ERISPrice
₹1,343.80
1M return
-0.67%
3M return
+0.10%
Market cap
₹18,620.67 cr
PE
43.17
ROE
+13.28%
RSI
47.13
Turnover
₹17.40 cr
Why it can matter in screens
- Momentum: ERIS is trend mixed or unavailable; RSI is 47.13.
- Returns: 1M -0.67%, 3M +0.10%, 6M -19.34%.
- Liquidity: latest turnover is ₹17.40 cr.
- Valuation: PE 43.17, PB n/a, ROE +13.28%, ROCE +13.76%.
- Growth: 3Y sales CAGR +29.48%, 3Y profit CAGR -4.67%.
Try these prompts
- Analyze ERIS LIFESCIENCES with valuation, momentum and industry peers
- Compare ERIS with other Healthcare stocks
- Show mid-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View mid-cap stocks
- Find stocks above 50DMA
- Compare ERIS with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.